SynthesisBMC cardiovascular disorders2026
Ketogenic diet-induced changes in adult lipid metabolism: a comprehensive systematic review and meta-regression of randomized controlled trials.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThe effects of the ketogenic diet (KD) on lipid metabolism remain controversial. We conducted a systematic review and meta-regression analysis of randomized controlled trials (RCTs) to evaluate the impact of KD on lipid profile parameters in adult populations.
methodsFive electronic databases (PubMed/MEDLINE, Web of Science, Scopus, Embase, Cochrane Library) were systematically searched from inception through June 2025 for RCTs examining lipid-related outcomes following KD interventions (defined as > 45% fat, < 10% carbohydrate). The DerSimonian-Laird method was used to figure out pooled weighted mean differences (WMDs) and 95% confidence intervals (CIs) using random-effects models. We conducted meta-regression, subgroup analyses, sensitivity analyses, and assessed publication bias. Study quality was assessed using the Cochrane Risk of Bias 2 tool and the GRADE framework.
resultsFifty-three RCTs met the inclusion criteria. Compared with control diets, KD significantly reduced triglycerides (WMD: -22.31 mg/dL; 95% CI: -28.90 to -15.72; p < 0.001; I2 = 69.8%, p < 0.001). HDL-C increased significantly (WMD: 3.52 mg/dL; 95% CI: 1.24 to 5.81; p < 0.001; I2 = 92.5%, p < 0.001). KD also raised LDL-C (WMD: 8.22 mg/dL; 95% CI: 5.08 to 11.40; p < 0.001; I2 = 59.9%, p < 0.001) and total cholesterol (WMD: 8.06 mg/dL; 95% CI: 3.04 to 13.07; p < 0.001; I2 = 72.3%, p < 0.001). Meta-regression revealed a significant negative correlation between changes in HDL-C and the duration of intervention (coefficient = − 0.125; p = 0.011). No evidence of publication bias was found, as Egger's test p-values exceeded 0.05 for all outcomes. According to the GRADE assessment, there is moderate certainty regarding TG and HDL-C, while certainty for LDL-C and TC remains low.
conclusionsKD causes an increase in HDL-C, LDL-C and total cholesterol while reducing triglycerides and. The long-term impact on heart and blood vessel health remains uncertain due to the lack of outcome data. These findings require careful interpretation and personalized monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.